Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP266828.RA5RauHjwfffepKl2vmKlMERn8oTprZBlFT7c_ImFYen4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP266828.RA5RauHjwfffepKl2vmKlMERn8oTprZBlFT7c_ImFYen4130_assertion type Assertion NP266828.RA5RauHjwfffepKl2vmKlMERn8oTprZBlFT7c_ImFYen4130_head.
- NP266828.RA5RauHjwfffepKl2vmKlMERn8oTprZBlFT7c_ImFYen4130_assertion description "[To investigate whether HHV-8 may contribute to PEL development in the absence of EBV, the expression of seven potentially oncogenic HHV-8 open reading frames (ORFs) (ORF72/viral cyclin D, ORF16/viral bcl-2, ORF74/viral G-protein coupled receptor, ORFK2/viral IL-6, ORFK13/viral FLICE inhibitory protein, ORFK9/viral interferon regulatory factor, and ORFK1, equivalent to the gene encoding herpesvirus saimiri transforming protein) was assessed by reverse transcriptase-polymerase chain reaction (RT-PCR) in an EBV-negative PEL presenting in an HIV-negative patient.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP266828.RA5RauHjwfffepKl2vmKlMERn8oTprZBlFT7c_ImFYen4130_provenance.
- NP266828.RA5RauHjwfffepKl2vmKlMERn8oTprZBlFT7c_ImFYen4130_assertion evidence source_evidence_literature NP266828.RA5RauHjwfffepKl2vmKlMERn8oTprZBlFT7c_ImFYen4130_provenance.
- NP266828.RA5RauHjwfffepKl2vmKlMERn8oTprZBlFT7c_ImFYen4130_assertion SIO_000772 10547588 NP266828.RA5RauHjwfffepKl2vmKlMERn8oTprZBlFT7c_ImFYen4130_provenance.
- NP266828.RA5RauHjwfffepKl2vmKlMERn8oTprZBlFT7c_ImFYen4130_assertion wasDerivedFrom befree-2016 NP266828.RA5RauHjwfffepKl2vmKlMERn8oTprZBlFT7c_ImFYen4130_provenance.
- NP266828.RA5RauHjwfffepKl2vmKlMERn8oTprZBlFT7c_ImFYen4130_assertion wasGeneratedBy ECO_0000203 NP266828.RA5RauHjwfffepKl2vmKlMERn8oTprZBlFT7c_ImFYen4130_provenance.